Synthesis and inhibitory activity of new benzimidazole derivatives against Burkitt’s lymphoma promotion
- 1 October 2007
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (19) , 6489-6496
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Green route for the heterocyclization of 2-mercaptobenzimidazole into β-lactum segment derivatives containing –CONH– bridge with benzimidazole: Screening in vitro antimicrobial activity with various microorganismsBioorganic & Medicinal Chemistry, 2006
- A facile microwave enhanced synthesis of sulfur-containing 5-membered heterocycles derived from 2-mercaptobenzothiazole over ZnCl2/DMF and antimicrobial activity evaluationJournal of Sulfur Chemistry, 2006
- Synthesis of 5‐Substituted 2‐Methylbenzimidazoles with Anticancer ActivityArchiv der Pharmazie, 2003
- Pyrrolo[1,2-a]benzimidazole-Based Quinones and Iminoquinones. The Role of the 3-Substituent on CytotoxicityJournal of Medicinal Chemistry, 1995
- A Comparison of the Cytotoxic and Physical Properties of Aziridinyl Quinone Derivatives Based on the Pyrrolo[1,2-a]benzimidazole and Pyrrolo[1,2-a]indole Ring SystemsJournal of Medicinal Chemistry, 1994
- Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agentsJournal of Medicinal Chemistry, 1991
- Preparation and Properties of the 5,6- and 4,6(5,7)-Dinitro Derivatives of Benzimidazole and their 1-β-D-RibofuranosidesNucleosides, Nucleotides & Nucleic Acids, 1989
- Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation; Ursolic acid and oleanolic acid from an anti-inflammatory Chinese medicinal plant, Glechoma hederaceae L.Cancer Letters, 1986
- Structural studies of a new antitumor agent: tiazofurin and its inactive analogsJournal of the American Chemical Society, 1983
- A short-term in vitro assay for promoter substances using human lymphoblastoid cells latently infected with Epstein-Barr virusCancer Letters, 1981